| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 2001 |
The Kitchen Picture Test (KPT): A new test of practical judgment
|
Mansbach, William
|
|
2013
|
9 |
4S |
p. P451
|
artikel
|
| 2002 |
The longer term impact of caregiver education on driving and dementia
|
D'Ambrosio, Lisa
|
|
2013
|
9 |
4S |
p. P339-P340
|
artikel
|
| 2003 |
The MCI Index: Risk assessment of cognitive decline
|
Kiernan, Ralph
|
|
2013
|
9 |
4S |
p. P442-P443
|
artikel
|
| 2004 |
The medial temporal lobe index (MTLi) is a simple and reliable method for predicting conversion from mild cognitive impairment to Alzheimer's disease
|
Menendez, Manuel
|
|
2013
|
9 |
4S |
p. P414-P415
|
artikel
|
| 2005 |
The metabolic model of Alzheimer's disease
|
Chauhan, Neelima
|
|
2013
|
9 |
4S |
p. P167-P168
|
artikel
|
| 2006 |
The Montreal Cognitive Assessment as a screen for MCI and dementia in African-American older adults
|
Goldstein, Felicia
|
|
2013
|
9 |
4S |
p. P784
|
artikel
|
| 2007 |
The natural history of the dynamics of beta-amyloid deposition, neurodegeneration and cognitive decline in sporadic Alzheimer's disease
|
Villemagne, Victor
|
|
2013
|
9 |
4S |
p. P523-P524
|
artikel
|
| 2008 |
The need for a large registry and clinical trials in young- and middle-aged apolipoprotein E ε4 homozygotes
|
Kuller, Lewis
|
|
2013
|
9 |
4S |
p. P634
|
artikel
|
| 2009 |
The neuroprotective and neurotrophic agent T-817MA for Alzheimer’s disease: Randomized, double-blind, placebo-controlled proof-of-concept trial outcomes
|
Schneider, Lon
|
|
2013
|
9 |
4S |
p. P530-P531
|
artikel
|
| 2010 |
The neuroprotective role of catalase overexpression in SH-SY5Y cells against beta-amyloid and H2O2 toxicity
|
Chilumuri, Amrutha
|
|
2013
|
9 |
4S |
p. P361
|
artikel
|
| 2011 |
The new criteria for detection and diagnosis of Alzheimer’s disease: From symptoms and signs to neuropsychology, neuroimaging and CSF
|
Scheltens, Philip
|
|
2013
|
9 |
4S |
p. P1
|
artikel
|
| 2012 |
The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease
|
Forman, Mark
|
|
2013
|
9 |
4S |
p. P139
|
artikel
|
| 2013 |
The novel calcium-binding protein EFHD2 is linked to frontotemporal dementia
|
Borger, Eva
|
|
2013
|
9 |
4S |
p. P355
|
artikel
|
| 2014 |
The nucleotide binding domain of heat shock cognate protein 70 (Hsc70) regulates tau clearance and stability
|
Fontaine, Sarah
|
|
2013
|
9 |
4S |
p. P315
|
artikel
|
| 2015 |
The number of dilated perivascular spaces: Hallmarks of mild cognitive impairment?
|
Yun, Young Hun
|
|
2013
|
9 |
4S |
p. P407
|
artikel
|
| 2016 |
The Orange County Vital Aging Program: A population roadmap for maintaining cognitive health—Three-year report
|
Fortier, Dennis
|
|
2013
|
9 |
4S |
p. P470
|
artikel
|
| 2017 |
The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative
|
Protas, Hillary
|
|
2013
|
9 |
4S |
p. P593
|
artikel
|
| 2018 |
The pattern of cerebral hypometabolism and its association with clinical ratings in cognitively normal older adults with and without significant fibrillar amyloid burden: Findings from the Alzheimer's Disease Neuroimaging Initiative
|
Protas, Hillary
|
|
2013
|
9 |
4S |
p. P68
|
artikel
|
| 2019 |
The perception of dementia in the general population in Japan
|
Umegaki, Hiroyuki
|
|
2013
|
9 |
4S |
p. P638-P639
|
artikel
|
| 2020 |
The Placebo Data Analysis in Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Clinical Trials Project: Overview of progress in trial data collection, and key findings from the pooled Alzheimer's disease trial datasets
|
Thomas, Ronald
|
|
2013
|
9 |
4S |
p. P665
|
artikel
|
| 2021 |
The 20-point short version MMSE is briefer but more accurate than the MMSE in screening dementia
|
Choe, Jin Yeong
|
|
2013
|
9 |
4S |
p. P458
|
artikel
|
| 2022 |
The powerful three: Music, movement and touch
|
Downey, Kathleen
|
|
2013
|
9 |
4S |
p. P649
|
artikel
|
| 2023 |
The practical utility of amyloid and FDG-PET in an academic dementia center
|
Juan, Pascual Sánchez
|
|
2013
|
9 |
4S |
p. P22
|
artikel
|
| 2024 |
The practical utility of amyloid and FDG-PET in an academic dementia center
|
Juan, Pascual Sánchez
|
|
2013
|
9 |
4S |
p. P267-P268
|
artikel
|
| 2025 |
The prevalence of amyloid pathology in healthy individuals and individuals with mild cognitive impairment: A meta-analysis of amyloid-PET studies
|
Jansen, Willemijn
|
|
2013
|
9 |
4S |
p. P533
|
artikel
|
| 2026 |
The prevalence of vascular cognitive impairment and its subtypes in Korean elders
|
Lee, Seok Bum
|
|
2013
|
9 |
4S |
p. P631-P632
|
artikel
|
| 2027 |
The proportional reasoning test: A novel assessment tool for Alzheimer's disease and frontotemporal dementias
|
Chey, Jeanyung
|
|
2013
|
9 |
4S |
p. P396
|
artikel
|
| 2028 |
The psychological impact of genetic risk information on individuals with mild cognitive impairment at imminent risk for conversion to Alzheimer's disease dementia: Findings from the REVEAL Study
|
Christensen, Kurt
|
|
2013
|
9 |
4S |
p. P546
|
artikel
|
| 2029 |
Therapeutic approaches to remedy deficits in glucose metabolism and mitochondria
|
Beal, Flint
|
|
2013
|
9 |
4S |
p. P826
|
artikel
|
| 2030 |
Therapeutic effects of long-acting intranasal insulin detemir for Alzheimer's dementia or mild cognitive impairment
|
Craft, Suzanne
|
|
2013
|
9 |
4S |
p. P139-P140
|
artikel
|
| 2031 |
The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
|
Novak, Gerald
|
|
2013
|
9 |
4S |
p. P287
|
artikel
|
| 2032 |
There is no evidence supporting population screening for dementia: Reporting on a systematic review of costs and benefits
|
Lafortune, Louise
|
|
2013
|
9 |
4S |
p. P845
|
artikel
|
| 2033 |
There is no preventive role of catechol-O-methyl transferase-inhibitor in Parkinson's disease associated with dementia
|
Jeong, Dushin
|
|
2013
|
9 |
4S |
p. P722-P723
|
artikel
|
| 2034 |
The relationship among intravenous immunoglobulin, the blood-brain barrier and Alzheimer's disease
|
Wuest, Diane
|
|
2013
|
9 |
4S |
p. P856
|
artikel
|
| 2035 |
The relationship among mTOR, beta-amyloid and tau: Therapeutic implications for Alzheimer's disease
|
Oddo, Salvatore
|
|
2013
|
9 |
4S |
p. P315
|
artikel
|
| 2036 |
The relationship between coping strategies and caregiver burden in caregivers of people with Alzheimer's dementia
|
Tutar, Hasan
|
|
2013
|
9 |
4S |
p. P484
|
artikel
|
| 2037 |
The relationship between CRA ADAS-Cog training and performance on monitoring ADAS-Cogs at clinical sites in an Alzheimer's disease clinical trial
|
Meyer, Stephen
|
|
2013
|
9 |
4S |
p. P285-P286
|
artikel
|
| 2038 |
The relationship between depressive symptoms and white matter lesions in elderly individuals with cognitive impairment
|
Kim, Dohoon
|
|
2013
|
9 |
4S |
p. P739
|
artikel
|
| 2039 |
The relationship between hassle severity, anxiety and cognitive performance: An 8-year follow-up in the Women's Healthy Aging Project
|
Desmond, Patricia
|
|
2013
|
9 |
4S |
p. P457
|
artikel
|
| 2040 |
The relationship between hippocampal atrophy and neuropathology markers: A 7T MRI study
|
Babakchanian, Sona
|
|
2013
|
9 |
4S |
p. P423
|
artikel
|
| 2041 |
The relationship between hippocampal atrophy and neuropathology markers: A 7T MRI study
|
Babakchanian, Sona
|
|
2013
|
9 |
4S |
p. P8-P9
|
artikel
|
| 2042 |
The relationship between IGFBP released from astrocyte and Alzheimer's disease
|
Watanabe, Kiwamu
|
|
2013
|
9 |
4S |
p. P180
|
artikel
|
| 2043 |
The relationship between insulin resistance and white matter integrity in middle-aged and older adults
|
Ryu, Seon Young
|
|
2013
|
9 |
4S |
p. P700
|
artikel
|
| 2044 |
The relationship between insulin resistance and white matter integrity in middle-aged and older adults
|
Ryu, Seon Young
|
|
2013
|
9 |
4S |
p. P108
|
artikel
|
| 2045 |
The relationship between psychotic symptoms of people with Alzheimer's disease and Theory of Mind skills and functionality
|
Oguten, Evrim Gode
|
|
2013
|
9 |
4S |
p. P790
|
artikel
|
| 2046 |
The relationship of cerebral perfusion with age and CSF measures in middle-aged adults at risk for Alzheimer's disease
|
Austin, Benjamin
|
|
2013
|
9 |
4S |
p. P216-P217
|
artikel
|
| 2047 |
The relationship of cerebral perfusion with age and CSF measures in middle-aged adults at risk for Alzheimer's disease
|
Austin, Benjamin
|
|
2013
|
9 |
4S |
p. P54-P55
|
artikel
|
| 2048 |
The reliability of and age effects on CSF measures of beta-amyloid 42 in beagle dogs: Implications for a natural animal model of Alzheimer's disease progression
|
Araujo, Joseph
|
|
2013
|
9 |
4S |
p. P851
|
artikel
|
| 2049 |
The rivastigmine high-dose, 13 mg/24h (15cm2), transdermal patch provides daily living benefits to people with severe Alzheimer's disease: Retrospective analyses of the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study
|
Cummings, Jeffrey
|
|
2013
|
9 |
4S |
p. P658
|
artikel
|
| 2050 |
The role of anxiety in the occurrence of dementia: The Rotterdam Study
|
de Bruijn, Renée
|
|
2013
|
9 |
4S |
p. P615
|
artikel
|
| 2051 |
The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies
|
Binnewijzend, Maja
|
|
2013
|
9 |
4S |
p. P38
|
artikel
|
| 2052 |
The role of ASL-measured cerebral blood flow in the differential diagnosis of Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies
|
Binnewijzend, Maja
|
|
2013
|
9 |
4S |
p. P377
|
artikel
|
| 2053 |
The role of autophagy in Alzheimer's disease
|
Orr, Miranda
|
|
2013
|
9 |
4S |
p. P189
|
artikel
|
| 2054 |
The role of common and rare variants in risk for Alzheimer's disease across populations
|
Farrer, Lindsay
|
|
2013
|
9 |
4S |
p. P677
|
artikel
|
| 2055 |
The role of CSF biomarkers in the diagnosis of frontotemporal dementia: New criteria offer new insights
|
Pijnenburg, Yolande
|
|
2013
|
9 |
4S |
p. P333-P334
|
artikel
|
| 2056 |
The role of Fbxo2 in APP turnover and processing
|
Atkin, Graham
|
|
2013
|
9 |
4S |
p. P186
|
artikel
|
| 2057 |
The role of functional genetic variation in Alzheimer's disease: The CHARGE consortium
|
Jakobsdottir, Johanna
|
|
2013
|
9 |
4S |
p. P519
|
artikel
|
| 2058 |
The ROSAS study: Baseline MRI characteristics
|
Bracoud, Luc
|
|
2013
|
9 |
4S |
p. P427-P428
|
artikel
|
| 2059 |
The ROSAS study: Baseline MRI characteristics
|
Bracoud, Luc
|
|
2013
|
9 |
4S |
p. P98-P99
|
artikel
|
| 2060 |
The San Francisco Dementia Support Network: Enhancing quality of care for persons with dementia in managed care
|
Edgerly, Elizabeth
|
|
2013
|
9 |
4S |
p. P473-P474
|
artikel
|
| 2061 |
The social experiences of spouses of persons with young-onset dementia (YOD): Social change, support and resiliency
|
Hawkins, Stacey
|
|
2013
|
9 |
4S |
p. P324
|
artikel
|
| 2062 |
The spread of prions
|
Sigurdson, Christina
|
|
2013
|
9 |
4S |
p. P673
|
artikel
|
| 2063 |
The stability of resting state networks in aging: Relevance for early memory dysfunction
|
Clerx, Lies
|
|
2013
|
9 |
4S |
p. P266
|
artikel
|
| 2064 |
The stability of resting state networks in aging: Relevance for early memory dysfunction
|
Clerx, Lies
|
|
2013
|
9 |
4S |
p. P55
|
artikel
|
| 2065 |
The statistical development of endpoints for Alzheimer's disease clinical trials
|
Raghavan, Nandini
|
|
2013
|
9 |
4S |
p. P677
|
artikel
|
| 2066 |
The study of MicRNA 107 and BACE1 mRNA gene expression in peripheral blood and cerebrospinal fluid of Alzheimer's disease
|
Wang, Tao
|
|
2013
|
9 |
4S |
p. P239
|
artikel
|
| 2067 |
The subclassifcation of amnestic MCI using MRI-based cortical thickness measures
|
Raamana, Pradeep
|
|
2013
|
9 |
4S |
p. P55-P56
|
artikel
|
| 2068 |
The subclassification of amnestic MCI using MRI-based cortical thickness measures
|
Raamana, Pradeep
|
|
2013
|
9 |
4S |
p. P402-P404
|
artikel
|
| 2069 |
The tau protein: From physiological to pathological process in Alzheimer's disease
|
Flores, Paola
|
|
2013
|
9 |
4S |
p. P366
|
artikel
|
| 2070 |
The therapeutic effects of icarrin on beta-amyloid burden in a mouse model of Alzheimer's disease
|
Zhang, Lan
|
|
2013
|
9 |
4S |
p. P506
|
artikel
|
| 2071 |
The three NITRCs: Software, data and cloud computing for brain science and dementia research
|
Shen, Li
|
|
2013
|
9 |
4S |
p. P78
|
artikel
|
| 2072 |
The three NITRCs: Software, data and cloud computing for brain science and dementia research
|
Shen, Li
|
|
2013
|
9 |
4S |
p. P255-P256
|
artikel
|
| 2073 |
The trajectory of cognitive decline in preclinical dementia in people attending a memory clinic: The 4C-MCI study
|
Hamel, Renske
|
|
2013
|
9 |
4S |
p. P445
|
artikel
|
| 2074 |
The Trajectory-Related Early Alzheimer's Database (TREAD) study
|
Darby, David
|
|
2013
|
9 |
4S |
p. P774
|
artikel
|
| 2075 |
The use of delayed matching-to-sample procedures in studies of short-term memory in people with dementia
|
Arntzen, Erik
|
|
2013
|
9 |
4S |
p. P753
|
artikel
|
| 2076 |
The use of patient-reported outcomes and observer-reported outcomes in Alzheimer's disease and dementia research
|
Dallabrida, Susan
|
|
2013
|
9 |
4S |
p. P663
|
artikel
|
| 2077 |
The use of reliable change indices to complement norms in the early identification of cognitive decline
|
Hayden, Kathleen
|
|
2013
|
9 |
4S |
p. P535-P536
|
artikel
|
| 2078 |
The utility of fluid biomarkers in research, trial design and clinical practice
|
Blennow, Kaj
|
|
2013
|
9 |
4S |
p. P827-P828
|
artikel
|
| 2079 |
THK523 selectively binds to neurofibrillary tangles and neuropils in people with Alzheimer's disease
|
Fodero-Tavoletti, Michelle
|
|
2013
|
9 |
4S |
p. P261-P262
|
artikel
|
| 2080 |
Three in one: Coexistence of essential tremor, idiopathic Parkinson's disease and dementia
|
Aydin, Mehmet
|
|
2013
|
9 |
4S |
p. P863-P864
|
artikel
|
| 2081 |
Three-year conversion of MCI to Alzheimer’s disease and cognitive decline can be predicted from polygenetic and imaging profiles
|
Yotter, Rachel
|
|
2013
|
9 |
4S |
p. P15-P16
|
artikel
|
| 2082 |
Three-year conversion of MCI to Alzheimer's disease and cognitive decline can be predicted from polygenetic and imaging profiles
|
Yotter, Rachel
|
|
2013
|
9 |
4S |
p. P724-P725
|
artikel
|
| 2083 |
Thrombopoietin and Alzheimer's disease
|
Edwards, Melissa
|
|
2013
|
9 |
4S |
p. P239
|
artikel
|
| 2084 |
Thymosin β4 and retinol-binding protein 4 as potential serum biomarkers for diagnosis of dementia with Lewy bodies
|
Nakashita, Satoko
|
|
2013
|
9 |
4S |
p. P236
|
artikel
|
| 2085 |
Time-course of behavioral and L-arginine metabolic profile changes in the APP SWE PS1 ΔE9 mouse model of Alzheimer's disease
|
Bergin, David
|
|
2013
|
9 |
4S |
p. P181
|
artikel
|
| 2086 |
Tn antigen in the brain: A newly recognized glycoprotein in Alzheimer's disease
|
Lalezari, Parviz
|
|
2013
|
9 |
4S |
p. P347-P348
|
artikel
|
| 2087 |
Too late or too little? Potential for Alzheimer's disease passive immunotherapy via targeted intracerebroventricular delivery
|
Nikolas, Lisa Jungbauer
|
|
2013
|
9 |
4S |
p. P807
|
artikel
|
| 2088 |
Topographic distribution of white matter hyperintense lesions and microbleeds in people with cognitive impairment
|
Montes, Angel Martã
|
|
2013
|
9 |
4S |
p. P385
|
artikel
|
| 2089 |
To what extent do common, age-related pathologies contribute to late life cognitive decline?
|
Boyle, Patricia
|
|
2013
|
9 |
4S |
p. P699-P700
|
artikel
|
| 2090 |
Tracking white matter degeneration in frontotemporal dementia using serial diffusion tensor imaging
|
Mahoney, Colin
|
|
2013
|
9 |
4S |
p. P56-P57
|
artikel
|
| 2091 |
Tracking white matter degeneration in frontotemporal dementia using serial diffusion tensor imaging
|
Mahoney, Colin
|
|
2013
|
9 |
4S |
p. P269
|
artikel
|
| 2092 |
Training for manual hippocampal segmentation based on the EADC-ADNI harmonized protocol
|
Boccardi, Marina
|
|
2013
|
9 |
4S |
p. P57-P58
|
artikel
|
| 2093 |
Training for manual hippocampal segmentation based on the EADC-ADNI harmonized protocol
|
Boccardi, Marina
|
|
2013
|
9 |
4S |
p. P404-P405
|
artikel
|
| 2094 |
Transcellular transmission of alpha-synuclein aggregates
|
Lee, Seung-Jae
|
|
2013
|
9 |
4S |
p. P673
|
artikel
|
| 2095 |
Transcranial Doppler cerebral blood flow velocity and cognitive function: Results from the Einstein Aging Study (EAS)
|
Ezzati, Ali
|
|
2013
|
9 |
4S |
p. P774-P775
|
artikel
|
| 2096 |
Transcranial magnetic stimulation–based observations in people with cortical dementias
|
Chandra, Sadanandavally
|
|
2013
|
9 |
4S |
p. P725
|
artikel
|
| 2097 |
Translating clinically relevant changes in the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-Cog) into changes in daily functions
|
Rockwood, Kenneth
|
|
2013
|
9 |
4S |
p. P320
|
artikel
|
| 2098 |
Traumatic brain injury and comorbid neuropsychiatric symptoms in an older veteran population
|
Wang, Sophia
|
|
2013
|
9 |
4S |
p. P542
|
artikel
|
| 2099 |
Treating Alzheimer's disease with an O-GlcNAcase inhibitor
|
Van Leuven, Fred
|
|
2013
|
9 |
4S |
p. P674
|
artikel
|
| 2100 |
Treatment of agitation in people with Alzheimer's dementia: Rationale for the clinical investigation of AVP-923 (dextromethorphan/quinidine)
|
Schoenfeld, Steven
|
|
2013
|
9 |
4S |
p. P757
|
artikel
|
| 2101 |
Treatment response prediction in people with Alzheimer's disease using EEG
|
Jóhannesson, Gísli
|
|
2013
|
9 |
4S |
p. P371
|
artikel
|
| 2102 |
TREM2 variants and young-onset Alzheimer's disease: A study of clinical phenotype
|
Slattery, Catherine
|
|
2013
|
9 |
4S |
p. P519
|
artikel
|
| 2103 |
Trichostatin A, a histone deacetylase inhibitor, modulates signaling pathways involved in the control of neuronal cholesterol metabolism
|
Nunes, Maria Joao
|
|
2013
|
9 |
4S |
p. P360
|
artikel
|
| 2104 |
Truncated tau causes microtubule disassembly with aging in tauopathy model mice
|
Matsumoto, Shin-ei
|
|
2013
|
9 |
4S |
p. P719
|
artikel
|
| 2105 |
Two distinct pathways leading to retinal degeneration in transgenic Drosophila melanogaster overexpressing human FUS
|
Hashimoto, Tadafumi
|
|
2013
|
9 |
4S |
p. P170
|
artikel
|
| 2106 |
Two rare AKAP9 missense variants are associated with Alzheimer’s disease in African-Americans
|
Logue, Mark
|
|
2013
|
9 |
4S |
p. P516-P517
|
artikel
|
| 2107 |
Two-year outcome in older adults with cognitive complaints: Relation to baseline cognition, self- and informant ratings, genetics and imaging
|
Saykin, Andrew
|
|
2013
|
9 |
4S |
p. P775-P776
|
artikel
|
| 2108 |
Type 2 diabetes as a risk factor for Alzheimer’s disease: A meta-analysis and systematic review of the confounders, interactions and neuropathology associated with this relationship
|
Vagelatos, Nicholas
|
|
2013
|
9 |
4S |
p. P136-P137
|
artikel
|
| 2109 |
Type 2 diabetes is associated with accelerated longitudinal white matter degeneration in the elderly
|
Maillard, Pauline
|
|
2013
|
9 |
4S |
p. P582
|
artikel
|
| 2110 |
Type 2 diabetes is associated with amnestic mild cognitive impairment, especially in women: Results of the Heinz Nixdorf Recall study
|
Winkler, Angela
|
|
2013
|
9 |
4S |
p. P610
|
artikel
|
| 2111 |
Tyrosine kinase inhibition promotes parkin-beclin-1–mediated protection in Alzheimer's disease models
|
Lonskaya, Irina
|
|
2013
|
9 |
4S |
p. P181-P182
|
artikel
|
| 2112 |
Unbiased estimates of CSF beta-amyloid 1-42 cut-points
|
Visser, Pieter Jelle
|
|
2013
|
9 |
4S |
p. P145-P146
|
artikel
|
| 2113 |
Underdiagnosis of cognitive impairment: Results from a postmortem study
|
Ferretti-Rebustini, Renata
|
|
2013
|
9 |
4S |
p. P750
|
artikel
|
| 2114 |
Understanding the target and evaluating the consequences of gamma-secretase modulation from in vitro models to higher-order species
|
Wood, Kathleen
|
|
2013
|
9 |
4S |
p. P814
|
artikel
|
| 2115 |
Unexpected impact of vitamin D deficiency: Disruption of vitamin D membrane receptor (1,25 MARRS) induces presenilin 1 expression
|
Gezen-Ak, Duygu
|
|
2013
|
9 |
4S |
p. P358
|
artikel
|
| 2116 |
Unnecessary hospital admissions from residential care for ambulatory care–sensitive conditions
|
Downs, Murna
|
|
2013
|
9 |
4S |
p. P310
|
artikel
|
| 2117 |
Update of novel type and more relevant model mouse for Alzheimer's disease
|
Saito, Takashi
|
|
2013
|
9 |
4S |
p. P329
|
artikel
|
| 2118 |
Update on hypothetical model of Alzheimer's disease biomarkers
|
Jack, Clifford
|
|
2013
|
9 |
4S |
p. P521-P522
|
artikel
|
| 2119 |
Upregulation of casein kinase 1 epsilon may be involved in tau pathology in Alzheimer's disease brain
|
Liu, Fei
|
|
2013
|
9 |
4S |
p. P720
|
artikel
|
| 2120 |
Use of CSF biomarkers in the differential diagnosis of early-onset cognitive impairment
|
Balasa, Mircea
|
|
2013
|
9 |
4S |
p. P367
|
artikel
|
| 2121 |
Use of lipidomics to identify novel blood-based phospholipid biomarkers that distinguish between mild cognitive impairment and early Alzheimer's disease
|
Abdullah, Laila
|
|
2013
|
9 |
4S |
p. P240
|
artikel
|
| 2122 |
Use of NeuroQuant automated volumetric MRI for Alzheimer's disease diagnosis
|
Dominguez, Jacqueline
|
|
2013
|
9 |
4S |
p. P422-P423
|
artikel
|
| 2123 |
Use of new technology to improve dementia prevention: The Healthy Aging Through Internet Counseling in the Elderly (HATICE) project
|
Mangialasche, Francesca
|
|
2013
|
9 |
4S |
p. P881
|
artikel
|
| 2124 |
Use of sleep deprivation as a translatable challenge to induce cognitive impairment in rodents and nonhuman primates: An IMI PHARMACOG initiative
|
Rahman, Anisur
|
|
2013
|
9 |
4S |
p. P154-P155
|
artikel
|
| 2125 |
Use of social media for recruitment in Alzheimer's disease research
|
Kurtzke, Margo
|
|
2013
|
9 |
4S |
p. P470
|
artikel
|
| 2126 |
Using a common sense model to predict willingness to be screened for mild cognitive impairment in a community sample of African-Americans
|
Gleason, Carey
|
|
2013
|
9 |
4S |
p. P546-P547
|
artikel
|
| 2127 |
Using cerebrospinal fluid markers to identify stages of National Institute on Aging and Alzheimer’s Association proposed criteria for preclinical Alzheimer's disease and its prognosis
|
Vos, Stephanie
|
|
2013
|
9 |
4S |
p. P682
|
artikel
|
| 2128 |
Using modern psychometric methods to improve measurement of cognition in Alzheimer’s disease clinical trials: Rationale and approach
|
Mungas, Dan
|
|
2013
|
9 |
4S |
p. P124
|
artikel
|
| 2129 |
Using morphology-specific reagents to distinguish between different neurodegenerative diseases
|
Williams, Stephanie
|
|
2013
|
9 |
4S |
p. P230
|
artikel
|
| 2130 |
Using primary neurons from transgenic mice to identify genes on human chromosome 21 influencing Alzheimer's neuropathology
|
Choong, Xun Yu
|
|
2013
|
9 |
4S |
p. P189
|
artikel
|
| 2131 |
Using visual attention to detect apathy in Alzheimer's disease
|
Lanctôt, Krista
|
|
2013
|
9 |
4S |
p. P524
|
artikel
|
| 2132 |
Utilising detailed neuropsychological assessment in the differential diagnosis of mild cognitive impairment, Alzheimer's disease, frontotemporal dementia and vascular dementia
|
Wakefield, Sarah
|
|
2013
|
9 |
4S |
p. P454
|
artikel
|
| 2133 |
Utility of amyloid PET in the differential diagnosis of dementia: An autopsy-confirmed series
|
Lehmann, Manja
|
|
2013
|
9 |
4S |
p. P334-P335
|
artikel
|
| 2134 |
Utility of amyloid PET in the differential diagnosis of dementia: An autopsy-confirmed series
|
Lehmann, Manja
|
|
2013
|
9 |
4S |
p. P38-P39
|
artikel
|
| 2135 |
Utility of the Spanish version of the FTLD-modified CDR in the diagnosis and staging of frontotemporal dementia complex
|
Buyatti, Daniela
|
|
2013
|
9 |
4S |
p. P320-P321
|
artikel
|
| 2136 |
Validation of an association between the CETP I405V variant and cognitive decline: The Cache County Study
|
Munger, Caitlin
|
|
2013
|
9 |
4S |
p. P561
|
artikel
|
| 2137 |
Validation of a novel cognitive composite assessment for mild and prodromal Alzheimer's disease
|
Harrison, John
|
|
2013
|
9 |
4S |
p. P661
|
artikel
|
| 2138 |
Validation of a Peruvian version of the Memory Alteration Test administered to people with amnestic mild cognitive impairment and early-stage Alzheimer's disease in Lima, Peru
|
Custodio, Nilton
|
|
2013
|
9 |
4S |
p. P765
|
artikel
|
| 2139 |
Validation of a polygenic risk score for dementia in the Health and Retirement Study
|
Daniel, Jessica
|
|
2013
|
9 |
4S |
p. P172
|
artikel
|
| 2140 |
Validation of a serum-based screen for Alzheimer's disease
|
O'Bryant, Sid
|
|
2013
|
9 |
4S |
p. P237-P238
|
artikel
|
| 2141 |
Validation of a telephone version of the Memory Alteration Test in healthy young adult volunteers
|
Ecay-Torres, Mirian
|
|
2013
|
9 |
4S |
p. P798
|
artikel
|
| 2142 |
Validation of beta-amyloid test as a reliable tool for quantifying beta-amyloid 1-40 and beta-amyloid 1-42 in blood
|
Pérez, Virginia
|
|
2013
|
9 |
4S |
p. P241
|
artikel
|
| 2143 |
Validation of next-generation sequencing technologies to radically change dementia genetic diagnosis
|
Beck, Jon
|
|
2013
|
9 |
4S |
p. P215
|
artikel
|
| 2144 |
Validation of the Alzheimer’s Disease Assessment Scale (ADAS) in Colombia: Preliminary results
|
Romero, Sara
|
|
2013
|
9 |
4S |
p. P323-P324
|
artikel
|
| 2145 |
Validation of the Alzheimer's Prevention Initiative Composite Cognitive Test Score
|
Ayutyanont, Napatkamon
|
|
2013
|
9 |
4S |
p. P320
|
artikel
|
| 2146 |
Validation of the 10/66 Dementia Research Group diagnostic instrument in Arabic
|
Phung, Kieu
|
|
2013
|
9 |
4S |
p. P757-P758
|
artikel
|
| 2147 |
Validation of the EADC-ADNI Harmonized Protocol for Manual Hippocampal Segmentation: Preliminary Results
|
Boccardi, Marina
|
|
2013
|
9 |
4S |
p. P868
|
artikel
|
| 2148 |
Validation of the Healthy Aging Brain Care monitor—Self-Report version
|
Alder, Catherine
|
|
2013
|
9 |
4S |
p. P639-P641
|
artikel
|
| 2149 |
Validation of the healthy brain checklist screening questionnaire in a community setting
|
Shankle, William
|
|
2013
|
9 |
4S |
p. P768
|
artikel
|
| 2150 |
Validation of the Healthy Brain Checklist screening questionnaire in a community setting
|
Shankle, William
|
|
2013
|
9 |
4S |
p. P119
|
artikel
|
| 2151 |
Validation of the Montreal Cognitive Assessment – Spanish Version test (MoCA-S) as a screening tool for mild cognitive impairment and mild dementia in Bogotá, Colombia
|
Gil, Laura
|
|
2013
|
9 |
4S |
p. P452-P453
|
artikel
|
| 2152 |
Validation of the Perceived Stress Scale in a community sample of older adults: Results from the Einstein Aging Study
|
Jiang, Julie
|
|
2013
|
9 |
4S |
p. P641
|
artikel
|
| 2153 |
Validation of the rowland universal dementia assessment scale as a multicultural screening test in danish memory clinics
|
Nielsen, T. Rune
|
|
2013
|
9 |
4S |
p. P322
|
artikel
|
| 2154 |
Validity and reliability of the neuropsychiatric inventory-clinician rating scale (NPI-C)© in a Brazilian multicenter study: Assessment of neuropsychiatric symptoms in dementia
|
Stella, Florindo
|
|
2013
|
9 |
4S |
p. P745-P746
|
artikel
|
| 2155 |
Validity of the short version of WAIS-III in geriatric population: Amnestic MCI, Alzheimer's disease and dementia with Lewy bodies
|
Ota, Kazumi
|
|
2013
|
9 |
4S |
p. P444
|
artikel
|
| 2156 |
Variables associated with cognitive impairment-no dementia in a low-educated cohort aged 75+ years: The Pietà study
|
Barbosa, Maira
|
|
2013
|
9 |
4S |
p. P776
|
artikel
|
| 2157 |
Variables associated with dementia in a low-educated cohort aged 75+ years: The Pietà study
|
Caramelli, Paulo
|
|
2013
|
9 |
4S |
p. P760
|
artikel
|
| 2158 |
Variant-domain mapping in confirmed late-onset Alzheimer disease (LOAD) loci identifies multiple genomic regions with potentially functional variants
|
Pericak-Vance, Margaret
|
|
2013
|
9 |
4S |
p. P557
|
artikel
|
| 2159 |
Variations in cognitive performance, demographics and health across community-based registries, from North Carolina to Tomsk, Russia
|
Germain, Cassandra
|
|
2013
|
9 |
4S |
p. P322
|
artikel
|
| 2160 |
Vascular disease, vascular risk factors and risk of late-onset Alzheimer's disease: Mendelian randomization analyses in the combined ADGC dataset
|
Mukherjee, Shubhabrata
|
|
2013
|
9 |
4S |
p. P694
|
artikel
|
| 2161 |
Vascular factors as predictors of severe dementia and mortality in Alzheimer's disease: The Cache County dementia progression study
|
Tschanz, JoAnn
|
|
2013
|
9 |
4S |
p. P738
|
artikel
|
| 2162 |
Vascular neuropathology in dementia patients receiving antipsychotic therapy
|
Jicha, Gregory
|
|
2013
|
9 |
4S |
p. P303
|
artikel
|
| 2163 |
Verbal memory performance in nondemented older adults with type 2 diabetes
|
Frazier, Darvis
|
|
2013
|
9 |
4S |
p. P796-P797
|
artikel
|
| 2164 |
Vertexwise discriminant analysis of ADNI [18F]florbetapir PET images for classification of amyloid-positive and amyloid-negative subjects
|
Charil, Arnaud
|
|
2013
|
9 |
4S |
p. P867
|
artikel
|
| 2165 |
Viewing neurodegeneration beyond the tangle: The role of RNA binding proteins in Alzheimer's disease
|
Wolozin, Benjamin
|
|
2013
|
9 |
4S |
p. P715-P716
|
artikel
|
| 2166 |
Viewing neurodegeneration beyond the tangle: The role of RNA binding proteins in Alzheimer's disease
|
Wolozin, Benjamin
|
|
2013
|
9 |
4S |
p. P847
|
artikel
|
| 2167 |
Visit-to-visit blood pressure variability and cognitive decline in Alzheimer's disease: Sub-analysis of results of the EXPECT trial
|
Shin, Joon Hyun
|
|
2013
|
9 |
4S |
p. P760
|
artikel
|
| 2168 |
Visual delayed recall as a predictor of conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment
|
Tabuchi, Hajime
|
|
2013
|
9 |
4S |
p. P879
|
artikel
|
| 2169 |
Visualization of beta-amyloid plaque reduction by small-molecule beta-amyloid oligomer aggregation inhibitors in hAPPSL transgenic mice
|
Muhs, Andreas
|
|
2013
|
9 |
4S |
p. P849
|
artikel
|
| 2170 |
Visualizing Alzheimer’s disease pathology with cholinesterase imaging agents
|
Macdonald, Ian
|
|
2013
|
9 |
4S |
p. P32
|
artikel
|
| 2171 |
Visualizing Alzheimer's pathology with cholinesterase imaging agents
|
Macdonald, Ian
|
|
2013
|
9 |
4S |
p. P197
|
artikel
|
| 2172 |
Visualizing complex patterns of dementia symptoms: A network approach
|
Mitnitski, Arnold
|
|
2013
|
9 |
4S |
p. P661
|
artikel
|
| 2173 |
Visual reproduction on the Wechsler Memory Scale-Revised as a predictor of Alzheimer's disease in Japanese people with mild cognitive impairment
|
Hori, Takumi
|
|
2013
|
9 |
4S |
p. P442
|
artikel
|
| 2174 |
Vitamin C and silymarin restores beta-amyloid oligomerization and behavioral abnormality in Alzheimer's disease pathology
|
Murakami, Kazuma
|
|
2013
|
9 |
4S |
p. P510
|
artikel
|
| 2175 |
Vitamin D and incident Alzheimer's disease in the Cardiovascular Health Cognition Study
|
Littlejohns, Thomas
|
|
2013
|
9 |
4S |
p. P880
|
artikel
|
| 2176 |
Vitamin D and incident dementia in the Cardiovascular Health Cognition Study
|
Soni, Maya
|
|
2013
|
9 |
4S |
p. P838
|
artikel
|
| 2177 |
Vitamin D3 and verbal fluency: Are higher levels better?
|
Pettersen, Jacqueline
|
|
2013
|
9 |
4S |
p. P606
|
artikel
|
| 2178 |
Vitamin D, the gamma-secretase modulator? Elevated presenilin 1 expression via beta-amyloid 1-42 is balanced with vitamin D
|
Dursun, Erdinc
|
|
2013
|
9 |
4S |
p. P358
|
artikel
|
| 2179 |
Volume of the cholinergic basal forebrain: A potential surrogate of brain resilience?
|
Wolf, Dominik
|
|
2013
|
9 |
4S |
p. P400
|
artikel
|
| 2180 |
Voxel-based morphometry patterns of social cognition in PPA and bvFTD
|
Couto, Blas
|
|
2013
|
9 |
4S |
p. P742
|
artikel
|
| 2181 |
Vulnerability to carer burden in the adult offspring carers of people with dementia
|
Dodge, Suzanne
|
|
2013
|
9 |
4S |
p. P645
|
artikel
|
| 2182 |
War-related risk factors for dementia in older veterans
|
Barnes, Deborah
|
|
2013
|
9 |
4S |
p. P839
|
artikel
|
| 2183 |
Wayfinding in elderly and Alzheimer's disease populations: A study in the vr-maze test
|
Morganti, Francesca
|
|
2013
|
9 |
4S |
p. P636
|
artikel
|
| 2184 |
What doesn't kill you makes you stronger: Mitochondrial hormesis and sirtuin 3
|
Bossy-Wetzel, Ella
|
|
2013
|
9 |
4S |
p. P825-P826
|
artikel
|
| 2185 |
What is the experience of being an APOE-ε4 homozygote? Findings from the REVEAL Study
|
Karlawish, Jason
|
|
2013
|
9 |
4S |
p. P621
|
artikel
|
| 2186 |
When to discontinue follow-up in phenocopy or nonprogressive behavioural variant fronto-temporal dementia
|
Jong, Frank Jan
|
|
2013
|
9 |
4S |
p. P746
|
artikel
|
| 2187 |
Where the rubber meets the road: Application and implications of the new Alzheimer’s disease criteria for primary care practice
|
Petersen, Ronald
|
|
2013
|
9 |
4S |
p. P1
|
artikel
|
| 2188 |
Which MCI subtypes convert to Alzheimer's disease in spite of negative CSF findings?
|
Damian, Marinella
|
|
2013
|
9 |
4S |
p. P859
|
artikel
|
| 2189 |
White matter cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease
|
Austin, Benjamin
|
|
2013
|
9 |
4S |
p. P842
|
artikel
|
| 2190 |
White matter degeneration in early- and late-myelinating tracts through the course of Alzheimer's disease
|
Benitez, Andreana
|
|
2013
|
9 |
4S |
p. P600-P601
|
artikel
|
| 2191 |
White matter hyperintensities and activities of daily living in people with dementia
|
Shin, Hae-Eun
|
|
2013
|
9 |
4S |
p. P746
|
artikel
|
| 2192 |
White matter hyperintensities are an independent predictor of cognitive dysfunctions and depression: Three-year follow-up study of vascular depression in community-dwelling elderly Koreans
|
Park, Joon Hyuk
|
|
2013
|
9 |
4S |
p. P600
|
artikel
|
| 2193 |
White matter hyperintensities in Alzheimer's disease: The potential protective role of vitamin D
|
Annweiler, Cedric
|
|
2013
|
9 |
4S |
p. P800
|
artikel
|
| 2194 |
White matter hyperintensities in mild cognitive impairment: Clinical impact of location and interaction with lacunes and medial temporal atrophy
|
Yoon, Bora
|
|
2013
|
9 |
4S |
p. P763
|
artikel
|
| 2195 |
White matter hyperintensities in the cholinergic tracts in people with MCI from the ADNI database longitudinal study
|
Charron, Geneviève Nolze
|
|
2013
|
9 |
4S |
p. P58
|
artikel
|
| 2196 |
White matter hyperintensities in the cholinergic tracts in people with MCI from the ADNI longitudinal study database
|
Charron, Geneviève Nolze
|
|
2013
|
9 |
4S |
p. P592
|
artikel
|
| 2197 |
White matter hyperintensity penumbra is differentially vulnerable to further degeneration in the elderly
|
Maillard, Pauline
|
|
2013
|
9 |
4S |
p. P400
|
artikel
|
| 2198 |
White matter injury and the orphan c2orf40 gene encoding Ecrg4 in Alzheimer's disease
|
Podvin, Sonia
|
|
2013
|
9 |
4S |
p. P352-P353
|
artikel
|
| 2199 |
White matter integrity predicts resting state network organization in mild cognitive impairment
|
Pardo, Jose Pineda
|
|
2013
|
9 |
4S |
p. P594-P595
|
artikel
|
| 2200 |
White matter lesions and neuropsychiatric symptoms in cognitively healthy individuals
|
Kim, Sang Ha
|
|
2013
|
9 |
4S |
p. P795
|
artikel
|
| 2201 |
White matter tract diffusion measurements in the general population
|
de Groot, Marius
|
|
2013
|
9 |
4S |
p. P108-P109
|
artikel
|
| 2202 |
White-matter tract diffusion measurements in the general population
|
de Groot, Marius
|
|
2013
|
9 |
4S |
p. P542-P543
|
artikel
|
| 2203 |
Whole cortical and DMN mean functional connectivity as potential biomarkers for mild Alzheimer's disease
|
Balthazar, Marcio
|
|
2013
|
9 |
4S |
p. P92
|
artikel
|
| 2204 |
Whole genome sequencing in an unresolved Alzheimer's disease family linked to 7q36
|
Cacace, Rita
|
|
2013
|
9 |
4S |
p. P173
|
artikel
|
| 2205 |
Who's yawning now? Sleep, depression, metabolism, and cognition in the Wisconsin Registry for Alzheimer's Prevention
|
Koscik, Rebecca
|
|
2013
|
9 |
4S |
p. P620-P621
|
artikel
|
| 2206 |
Why they stay: Understanding participant retention in Alzheimer's disease research
|
Geramian, Helene
|
|
2013
|
9 |
4S |
p. P649
|
artikel
|
| 2207 |
Widespread disruption of functional brain organization in early-onset Alzheimer's disease patients
|
Adriaanse, Sofie
|
|
2013
|
9 |
4S |
p. P685
|
artikel
|
| 2208 |
Widespread disruption of functional brain organization in people with early-onset Alzheimer's disease
|
Adriaanse, Sofie
|
|
2013
|
9 |
4S |
p. P111
|
artikel
|
| 2209 |
Wild-type and mutant tau expression affects APP processing
|
Brion, Jean-Pierre
|
|
2013
|
9 |
4S |
p. P142
|
artikel
|
| 2210 |
Willingness to be screened for mild cognitive impairment in a community sample of African-Americans: Role of stigma and social support
|
Gunn, Wade
|
|
2013
|
9 |
4S |
p. P474-P475
|
artikel
|
| 2211 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P465
|
artikel
|
| 2212 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P441
|
artikel
|
| 2213 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P172
|
artikel
|
| 2214 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P453
|
artikel
|
| 2215 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P488
|
artikel
|
| 2216 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P396
|
artikel
|
| 2217 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P601
|
artikel
|
| 2218 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P570
|
artikel
|
| 2219 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P180
|
artikel
|
| 2220 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P204
|
artikel
|
| 2221 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P787
|
artikel
|
| 2222 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P574
|
artikel
|
| 2223 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P196
|
artikel
|
| 2224 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P607
|
artikel
|
| 2225 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P651
|
artikel
|
| 2226 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P95
|
artikel
|
| 2227 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P283
|
artikel
|
| 2228 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P491
|
artikel
|
| 2229 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P785
|
artikel
|
| 2230 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P141
|
artikel
|
| 2231 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P808
|
artikel
|
| 2232 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P548
|
artikel
|
| 2233 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P209
|
artikel
|
| 2234 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P702
|
artikel
|
| 2235 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P254
|
artikel
|
| 2236 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P236
|
artikel
|
| 2237 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P460
|
artikel
|
| 2238 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P363
|
artikel
|
| 2239 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P364
|
artikel
|
| 2240 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P620
|
artikel
|
| 2241 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P258
|
artikel
|
| 2242 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P467
|
artikel
|
| 2243 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P314
|
artikel
|
| 2244 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P325
|
artikel
|
| 2245 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P363
|
artikel
|
| 2246 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P103
|
artikel
|
| 2247 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P349
|
artikel
|
| 2248 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P607
|
artikel
|
| 2249 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P360
|
artikel
|
| 2250 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P784
|
artikel
|
| 2251 |
Withdrawn
|
|
|
2013
|
9 |
4S |
p. P457
|
artikel
|
| 2252 |
X-ray fluorescence imaging of metal ion content in PSAPP mouse brain
|
James, Simon
|
|
2013
|
9 |
4S |
p. P246-P247
|
artikel
|
| 2253 |
Zonisamide improves parkinsonism of DLB/PDD without worsening psychiatric symptoms
|
Kowa, Hisatomo
|
|
2013
|
9 |
4S |
p. P804
|
artikel
|
Tijdschrift beschrijving